Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients

ConditionBacterial Infections

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

Patients may benefit from the personalized β-lactams dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review, prospective observe and analyze the clinical outcomes of patients with liver cirrhosis, and to build a population pharmacokinetics model in the population mentioned above.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

β-lactams

Treatment groups

1,000 Participants

are divided into 1 treatment group

Sponsors and collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

Source ClinicalTrials.gov